Risk Factors Associated with MDR-TB among Tuberculosis Patients in Ibadan, Oyo state, Nigeria
Keywords:
TB Patients, MDR-TB, tuberculosis, Risk factorsAbstract
Introduction: In Nigeria, patients accessing Directory Observed Therapy (DOTS) treatment are exposed to resistance to anti-TB drugs, hence is considered a priority, only few studies have focused on the relevant risk factors, Factors leading to development of drug resistance need to be understood to develop appropriate control strategies for national programs
Method: The study was a cross sectional study design. Multistage sampling technique was employed in the selection of403 tuberculosis patients in Ibadan North Local Government Area of Oyo State. Data were collected using self-administered structured questionnaire, and analyzed using SPSS version 25. Level of significance was set at P<0.05.
Results: Fifty three (13.2%) of the total respondent had Multidrug Resistant TB (MDR-TB) which is more among the males 36(67.9%) (p>0.05). Education and Occupation shows a significant association with MDR-TB, (χ2=24.640, p = 0.007) and (χ2=14.416, p = 0.006) respectively,risk factors such asprevious TB treatment and Adherence with treatment regimen (r=0.270, p<0.05), HIV (r=0.168, p<0.05) and smoking (ß=0.107, t=2.144, p<0.05) were statistically associated with development of acquired MDR-TB.
Conclusion: This finding revealed that Previous TB treatment andAdherence with treatment regimen were found to be the major risk factor for MDR-TB. Targeted educational intervention for patients and their contacts may minimize the nonadherence with prescribed TB treatment and lessen MDR-TB magnitude. High quality directly observed treatment should be strengthened to ensure that the previously treated patients can receive standard and regular regimens.
References
World Health Organisation. Global Tuberculosis Journal of Recent Scientific Research, November,
Control: WHO report Geneva, Switzerland: 2016. 2013Vol. 4, Issue,11, pp.1831-1834
Abdulhalik Workicho Wondwosen Kassahun 13. Mesfin YM, Hailemariam D, Biadgilign S, Kibret
Fessahaye Alemseged, Risk factors for multidrug- KT. Association between HIV/AIDS and multi-drug
resistant tuberculosis among tuberculosis patients: a resistance tuberculosis: a systematic review and
case-control study Infect Drug Resist. 2017; 10:
–96. doi: 10.2147/ IDR.S126274 meta-analysis. PLoS One. 2014; 9(1):e82235.
Casal, M., Vaquero, M, Rinder, H, Tortoli, E, Grosset,
Xin-Tong Lv,, Xi-Wei Lu,, Xiao-Yan Shi and Ling S. Rusch-Gerdes J and Jalier V. "A case-control study
Zhou,Prevalence and risk factors of multi-drug for multidrug-resistant tuberculosis: risk factors in
resistant tuberculosis in Dalian, China Journal of four European countries." Microbial Drug
International Medical Research 2017, Vol. 45(6)
–1786 DOI: 10.1177/030006051 6687429 Resistance, 2005: 11(1): 62-67.
Federal Ministry of Health (2015): NATIONAL
Solomon WeldegebrealAsgedom , Mebrahtu Tuberculosis, Leprosy and Buruh ulcer management
Teweldemedhin, and Hailay Gebreyesus Prevalence of Multidrug-Resistant Tuberculosis and Associated and control Guidelines sixth edition.
Factors in Ethiopia: A Systematic Review Journal of 16. Chen S, Huai P, Wang X, Zhong J, Wang X, Wang K,
Pathogens Volume 2018, Article ID 7104921, 8 Risk factors for multidrug-resistance among
pages https://doi.org/10.1155/2018/7104921 previously treated patients with tuberculosis in eastern china: a casecontrol study. International
World Health Organization. Multi drug and Journal of Infectious Diseases 2013: 17(12): 1116-
Extensively drug resistant TB (M / X DR-TB), 1120. DOI: 10.1016/j.ijid.2013.06.006
Global report on surveillance and response Geneva
(2010) (WHO/HTM/TB/2010.3) 17. MahfuzaRifat, , AbulHasnat Milton, John Hall,
Christopher Oldmeadow, Md. Akramul Islam,
Ani AT, Idoko J, Dalyop YB, Pitman SL, Drug Ashaque Husain, Md. and BodrunNaherSiddiquea
resistance profile of Mycobacterium tuberculosis Development of Multidrug Resistant Tuberculosis in
isolated from pulmonary tuberculosis patients in Jos, Bangladesh: A Case-Control Study on Risk Factors
Nigeria. Transaction of the Royal Society of Tropical PLoS One. 2014; 9(8): e105214 PMCID:
Medicine and Hygiene (2009) 103: 87-71. PMC4138182 doi: 10.1371/journal.pone.0105214
Kehinde AO, Obaseki FA, Ishola OC, Ibrahim KD 18. Kliiman, M.D. and Altraja, A. Predictors of
Extensively Drug-Resistant Pulmonary in Botswana Int J Tuberc Lung Dis. 2012 Nov;
Tuberculosis. Annals of Internal Medicine, 2009: 16(11): 1529–1534doi: 10.5588/ijtld. 12.0026
, 766-775. http://dx.doi.org/10.7326/0003-4819- 27. Gómez-Gómez A, Magaña-Aquino M, López-Meza
-11-200906020-00004 S, et al. Diabetes and Other Risk Factors for Multi-
Marahatta et al: Risk factors for MDRTB in central drug Resistant Tuberculosis in a Mexican Population
NEPA! A Pilastudy Medical Journal 2010: 8(32) with Pulmonary Tuberculosis: Case Control Study.
:392-7. Arch Med Res. 2015;46(2): 142–148.
Andrews JR, Shah NS, Weissman D, Moll AP, 28. Mishal S Khan, Coll Hutchison, Richard J Coker,
Friedland G, et al. Predictors of Multidrug- and Joanne Yoong, Khaung M Hane,Anh L Innes, Tin M
Extensively Drug-Resistant Tuberculosis in a High Khaing, SithuAung. Preventing emergence of drug
HIV Prevalence Community. PLoS ONE (2010) resistant tuberculosis in Myanmar's transitioning
(12): e15735. doi:10.1371/journal. pone.0015735 health system Health Policy and Planning, Volume
Romieu, I. and C. Trenga, From exposure to disease: 32, Issue suppl_2, 1 October 2017, Pages ii43–ii50,
the role of environmental factors in susceptibility to https://doi.org/ 10.1093/heapol/czx093
and development of tuberculosis,” Epidemiologic 29. Gomes, M, Correia A, Mendonca, D &Duartes, R.
Reviews. 2001:.“ 23(2):288–301. Risk Factors for Drug Resistant Tuberculosis.
Liu, Q., Zhu, L., Shao, Y., Song, H., Li, G., Zhou, Y., Journal of Tuberculosis Research 2:111-118.
Yang Z, Jinyan S, Chongqiao Z, Cheng C and Wei, L. Published Online September 2014 in SciRes.
Rates and Risk Factors for Drug Resistance Available from: http://www.scirp.org/journal/jtr
Tuberculosis in Northeastern China. BMC Public (accessed 27 July, 2018).
Health, (2013) 13, 1171. http://dx.doi.org/10.1186/ 30. Abubakar, I, Zignol, M &Raviglione M .Drug-
-2458-13-1171 resistant tuberculosis: time for visionary political
Fikadu Tadesse, Risk Factors for Multi-drug leadership. Elsevier. Available from: http://www.
Resistant Tuberculosis in Addis Ababa, Ethiopia sciencedirect. com/science/article/pii/S147330
Universal Journal of Public Health 3(2): 65-70, 2015 9913700306 2013 (accessed 7 July, 2018).
DOI: 10.13189/ujph.2015.030203 31. World Health Organization (WHO).Global
Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie tuberculosis report 2015 (internet). Geneva: WHO,
S, Kumera G. Multidrug resistant tuberculosis: 2015. (cited 2018 Jun 03) Available from:
prevalence and risk factors in districts of metema and http://apps.who.int/iris/bitstream/10665/191102/1/9
west armachiho, Northwest Ethiopia. BMC Infect 789241565059_eng.pdf?ua=1
Dis. 2015;15 (1):461 32. WHO, 2009 update TUBERCULOSIS FACTS
Shin SS, Mathew TA, Yanova GV, et al. Alcohol 33. Ming-Gui Wang, Wei-Wei Huang, Yu Wang, Yun-Xia
consumption among men and women with Zhang,(2018)Association between tobacco smoking
tuberculosis in Tomsk, Russia. Cent Eur J Public and drug-resistant tuberculosis Infect Drug Resist.
Health. 2010;18:132–138. 2018; 11: 873–887 PMCID: PMC6003534 doi:
Zetola, NM, Modongo, C Kip,EC, Gross,R, * Bisson,GP and Collman RG. Alcohol use and abuse among patients with multidrug-resistant tuberculosis 10.2147/IDR.S164596
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Research Journal of Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.
